速報APP / 醫療 / JHLT

JHLT

價格:免費

更新日期:2019-07-16

檔案大小:14M

目前版本:7.5.1

版本需求:Android 4.4 以上版本

官方網站:http://www.elsevier.com

Email:JBSMobileReleaseTeam@elsevier.com

聯絡地址:3251 Riverport Lane Maryland Heights, MO 63043

JHLT(圖1)-速報App

The Journal of Heart and Lung Transplantation

The Official Publication of the International Society for Heart and Lung Transplantation

JHLT(圖2)-速報App

It just got a whole lot easier to keep up with the latest research of the failing heart and lung. The Journal of Heart and Lung Transplantation app brings you the convenience of reading your favorite journal from anywhere in the world with just a tap. Now available for android smartphones and tablets!

• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month

JHLT(圖3)-速報App

• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.

• Get access to the journal content on the app via your institution’s IP

JHLT(圖4)-速報App

• Enjoy Open Access and Open Archive Content without having to login

• Accessibility support to assist the visually impaired

JHLT(圖5)-速報App

• Interact with figures, tables, and supplementary content

• Stream multimedia for faster viewing or download for later

JHLT(圖6)-速報App

• Take notes, highlight articles and share via email and social media

• Personalize your experience with My Reading List and save articles for offline reading

JHLT(圖7)-速報App

Journal Subscribers: Log in with the same username and password that grants you access to the full journal content on the Journal of Heart and Lung Transplantation website. These credentials will allow full access to all content on the app.

About The Journal of Heart and Lung Transplantation

JHLT(圖8)-速報App

The Official Publication of the International Society for Heart and Lung Transplantation, The Journal of Heart and Lung Transplantation brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas.

Our privacy policy is here: http://www.elsevier.com/EULA_non-Apple_apps